Description
University of Pittsburgh researchers have found that daily administration of semapimod decreases the protein expression of HMGB1, Bad, Bax and COX-2 in the intestines of formula-fed newborn rats exposed to hypoxia and protects against chronic intestinal injury in an animal model of necrotizing enterocolitis (NEC).
IP Status
https://patents.google.com/patent/US8314149B2